Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-009848·Apeiron Investment Group Ltd.
Schedule 13D ownership disclosure
NEUPHORIA THERAPEUTICS INC
Common Stock · CUSIP: 64136E102
Event date: 2025-01-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Apeiron Investment Group Ltd.Reported CIK 0001845711
Shares: 72,618 · Class: 4.5%
- Apeiron Presight Capital Fund II, L.P.Reported CIK 0001840676
Shares: 0 · Class: 0%
- Presight Capital Management I, L.L.C.
Shares: 0 · Class: 0%
- Fabian Hansen
Shares: 0 · Class: 0%
- Christian AngermayerReported CIK 0001845872
Shares: 72,618 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-009848
- Form type
- SCHEDULE 13D/A
- Filer
- Apeiron Investment Group Ltd.
- CIK
- CIK 1845711
- Filed
- Jan 28, 2025
- Reporting period
- Jan 24, 2025
- Description
- Schedule 13D beneficial ownership